|
|
Article: A BIG GUN IN TOUGH SPOT
- Article from:
- The Boston Globe (Boston, MA)
- Article date:
- February 13, 2003
- Author:
CopyrightCopyright 2003 The Boston Globe. Provided by ProQuest LLC. (Hide copyright information)
|
The odds of earning a buck investing in any young biotech company
are horse-track long. Any chief executive who can make that
proposition work profitably over and over is doing something special.
Mark Skaletsky is my candidate for the most successful serial CEO
of Massachusetts biotech start-ups. It's been 23 years since
Skaletsky resigned a job at Bristol-Myers to work above a Cambridge
restaurant as the third American employee at an obscure new company,
Biogen Inc. He left years later, by then the public Biogen's
president, to run another new, local venture that was later sold
profitably as it prepared to go public. Still later, Skaletsky hit it
big with yet another start-up, Geltex ...